Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Inovio Stock Shows Plenty of Promise Ahead

By Chris Lau, InvestorPlace Contributor

The clinical results from Inovo's INO-4700 validate the upside potential in INO stock.

Beleaguered American Airlines Stock May Have Nearly 80% Upside From Here

By Chris Lau, InvestorPlace Contributor

AAL stock is a gamble for speculators. Value investors should wait for more evidence that airline traffic is improving at a sharp pace.

7 Tech Stocks to Buy Amidst Coronavirus Uncertainty

By Chris Lau, InvestorPlace Contributor

Big megatrends ahead, including 5G, Artificial Intelligence and cloud computing all assure strong growth for various specific tech stocks.

After Berkshire Sold Its Airline Stocks, Should Investors Still Own United Airlines?

By Chris Lau, InvestorPlace Contributor

UAL stock is benefiting from lower costs, but passenger flight volumes must recover before investors may safely buy the shares again.

BP Stock Is a Good Way to Bet on a Full Economic Recovery

By Chris Lau, InvestorPlace Contributor

BP has a high amount of cash, so after it decided to maintain its dividend, income investors do not need to sell BP stock.

Load More